😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

European stocks mixed; results from Barclays, Deutsche Bank in focus

Published 2023/04/27, 10:20
© Reuters.
EUR/USD
-
UK100
-
XAU/USD
-
FCHI
-
DE40
-
BARC
-
DBKGn
-
PERP
-
BBVA
-
AZN
-
ULVR
-
GC
-
LCO
-
CL
-
FRCB
-
B1CS34
-

Investing.com - European stock markets traded in a mixed fashion Thursday, as investors digested a deluge of corporate earnings, with the banking sector in particular focus.

At 04:05 ET (08:05 GMT), the DAX index in Germany traded 0.1% lower, the FTSE 100 in the U.K. fell 0.2%, while the CAC 40 in France climbed 0.2%.

The quarterly corporate season is in full flow in Europe, with the banking sector to the fore.

Barclays (LON:BARC) stock rose 3.1% after the British lender reported better-than-expected first-quarter profit on Thursday after a strong performance from its credit card business.

Deutsche Bank (ETR:DBKGn) stock rose 0.5% after the German banking giant posted a better-than-expected 9% rise in first-quarter profit, its 11th straight quarterly profit, as income from higher interest rates offset a slump in revenues at the investment bank.

BBVA (BME:BBVA) stock rose 1.4% after the Spanish bank reported its first-quarter net profit rose almost 40% from the same quarter in 2022 thanks to a solid performance in Mexico, its main market.

These largely positive results in Europe have helped ease worries about contagion after U.S. regional lender First Republic Bank (NYSE:FRC) slumped 30% Wednesday, adding to similar losses the previous session, after the bank revealed $100 billion in customer withdrawals last month, raising fears about its long term viability.

Away from the financial sector, Unilever (LON:ULVR) stock rose 1.4% after the packaged goods giant easily beat quarterly sales forecasts on Thursday, as big price rises compensated for a small dip in volumes.

AstraZeneca (LON:AZN) stock rose 0.9% after the drugmaker beat expectations for its first-quarter profit and revenue, helped by sales of its roster of drugs in emerging markets.

On the flip side, Pernod Ricard (EPA:PERP) stock fell 0.1% after the French spirits group reported disappointing sales in the third quarter, but said it was still confident of delivering a strong performance over the 2022/2023 full year.

In economic news, Spanish retail sales jumped 9.5% on the year in March, a significant improvement on the revised 4.1% rise the previous month, while Italian business and consumer confidence remained healthy.

Oil prices edged higher Thursday, helped by a much larger-than-expected drop in weekly U.S. crude inventories, but are on course for a losing week on concerns slowing economic growth will hit future oil demand.

U.S. crude stocks fell by 5.1 million barrels last week, following a 4.6M barrel draw in the prior week and below the expected 1.5M barrel decrease, according to data from the Energy Information Administration, released late Wednesday.

By 04:05 ET, U.S. crude futures traded 0.4% higher at $74.58 a barrel, while the Brent contract climbed 0.5% to $78.14.

Both benchmarks are on course to post losses of almost 4% this week, close to a one-month low, having erased all the gains made on the back of a surprise production cut by the Organization of Petroleum Exporting Countries and allies at the start of this month. 

Additionally, gold futures rose 0.6% to $2,008.00/oz, while EUR/USD traded 0.1% higher at 1.1044.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.